Pfizer to buy Baxter International's vaccines unit for $635 million

Pfizer to buy Baxter International's vaccines unit for $635 million
(Image credit: Spencer Platt/Getty Images)

Pharmaceutical giant Pfizer Inc. agreed Wednesday to buy the vaccines unit of Baxter International Inc. in a $635 million deal, Reuters reports.

Through the acquisition, Pfizer will have access to Baxter's meningitis vaccine and its encephalitis vaccine, both of which are currently available outside of the United States. Pfizer will also gain access to part of Baxter's vaccine production facility in Austria.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Kimberly Alters

Kimberly Alters is the news editor at TheWeek.com. She is a graduate of the Medill School of Journalism at Northwestern University.